These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27854556)

  • 1. Drospirenone Litigation: Does the Punishment Fit the Crime?
    Batur P; Casey PM
    J Womens Health (Larchmt); 2017 Feb; 26(2):99-102. PubMed ID: 27854556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives.
    Dinger J; Bardenheuer K; Heinemann K
    Contraception; 2014 Apr; 89(4):253-63. PubMed ID: 24576793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of venous thromboembolism in women taking the combined oral contraceptive: A systematic review and meta-analysis.
    Bateson D; Butcher BE; Donovan C; Farrell L; Kovacs G; Mezzini T; Raynes-Greenow C; Pecoraro G; Read C; Baber R
    Aust Fam Physician; 2016; 45(1):59-64. PubMed ID: 27051991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACOG Committee Opinion Number 540: Risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills.
    Committee on Gynecologic Practice
    Obstet Gynecol; 2012 Nov; 120(5):1239-42. PubMed ID: 23090561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel.
    Heinemann K; Heinemann LA
    J Fam Plann Reprod Health Care; 2011 Jul; 37(3):132-5. PubMed ID: 21659330
    [No Abstract]   [Full Text] [Related]  

  • 6. Drospirenone and VTE.
    Leppée M; Eric M; Culig J
    J Fam Plann Reprod Health Care; 2010 Jan; 36(1):44. PubMed ID: 20067674
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral hormonal contraception and venous thromboembolism (VTE).
    Reid RL
    Contraception; 2014 Apr; 89(4):235-6. PubMed ID: 24594431
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data.
    Jick SS; Hernandez RK
    BMJ; 2011 Apr; 342():d2151. PubMed ID: 21511805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
    Sehovic N; Smith KP
    Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database.
    Parkin L; Sharples K; Hernandez RK; Jick SS
    BMJ; 2011 Apr; 342():d2139. PubMed ID: 21511804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.
    Lidegaard Ø; Nielsen LH; Skovlund CW; Skjeldestad FE; Løkkegaard E
    BMJ; 2011 Oct; 343():d6423. PubMed ID: 22027398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The INAS-OC study.
    Lidegaard O
    Contraception; 2014 Dec; 90(6):617-8. PubMed ID: 25261151
    [No Abstract]   [Full Text] [Related]  

  • 13. Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study.
    Gronich N; Lavi I; Rennert G
    CMAJ; 2011 Dec; 183(18):E1319-25. PubMed ID: 22065352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply to letter to the editor: "The INAS-OC study".
    Dinger J
    Contraception; 2014 Dec; 90(6):618-21. PubMed ID: 25263612
    [No Abstract]   [Full Text] [Related]  

  • 15. Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters.
    Larivée N; Suissa S; Coulombe J; Tagalakis V; Filion KB
    Drug Saf; 2017 Jul; 40(7):583-596. PubMed ID: 28382493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective.
    Raymond EG; Burke AE; Espey E
    Obstet Gynecol; 2012 May; 119(5):1039-44. PubMed ID: 22525916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives.
    Dinger J; Möhner S; Heinemann K
    Contraception; 2016 May; 93(5):378-85. PubMed ID: 26825258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of deep venous thrombosis with oral contraceptives containing drospirenone.
    Dunn N
    BMJ; 2011 Apr; 342():d2519. PubMed ID: 21511807
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
    Dinger J; Assmann A; Möhner S; Minh TD
    J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drospirenone-containing oral contraceptive pills and the risk of venous thromboembolism: a systematic review of observational studies.
    Larivée N; Suissa S; Khosrow-Khavar F; Tagalakis V; Filion KB
    BJOG; 2017 Sep; 124(10):1490-1499. PubMed ID: 28276140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.